What is the projected market valuation for the US peripheral nerve-stimulators market in 2035?

The projected market valuation for the US peripheral nerve-stimulators market in 2035 is $192.0 Million. Read More

What was the overall market valuation for the US peripheral nerve-stimulators market in 2024?

The overall market valuation for the US peripheral nerve-stimulators market in 2024 was $112.0 Million. Read More

What is the expected CAGR for the US peripheral nerve-stimulators market during the forecast period 2025 - 2035?

The expected CAGR for the US peripheral nerve-stimulators market during the forecast period 2025 - 2035 is 5.02%. Read More

Which companies are considered key players in the US peripheral nerve-stimulators market?

Key players in the US peripheral nerve-stimulators market include Medtronic, Boston Scientific, Abbott, Nevro Corporation, Stryker, Nuvectra, Stimwave Technologies, and Halyard Health. Read More

What are the projected revenues for the Transcutaneous segment in the US peripheral nerve-stimulators market?

The projected revenues for the Transcutaneous segment in the US peripheral nerve-stimulators market range from $40.0 Million to $66.0 Million. Read More

How do the revenues for Implantable devices compare to those for Percutaneous devices in the market?

The revenues for Implantable devices are projected to range from $42.0 Million to $76.0 Million, whereas Percutaneous devices range from $30.0 Million to $50.0 Million. Read More

What is the revenue range for Stimulator Machines with Train of Four (TOF) Monitoring Features?

The revenue range for Stimulator Machines with Train of Four (TOF) Monitoring Features is projected to be between $40.0 Million and $68.0 Million. Read More

What segment is expected to generate the highest revenue among end users in the US peripheral nerve-stimulators market?

Among end users, Hospitals & Clinics are expected to generate the highest revenue, projected to range from $70.0 Million to $120.0 Million. Read More

What is the revenue range for Continuous Peripheral Nerve Blocks (CPNB) Catheters in the market?

The revenue range for Continuous Peripheral Nerve Blocks (CPNB) Catheters is projected to be between $30.0 Million and $50.0 Million. Read More

What are the projected revenues for Pain Pumps in the US peripheral nerve-stimulators market?

The projected revenues for Pain Pumps in the US peripheral nerve-stimulators market range from $22.0 Million to $42.0 Million. Read More

What is the expected compound annual growth rate (CAGR) for the US Peripheral Nerve Stimulators Market from 2025 to 2035?

The expected CAGR for the US Peripheral Nerve Stimulators Market from 2025 to 2035 is 5.113%. Read More

Which product type is projected to generate the highest market value by 2035?

By 2035, the Implantable segment is anticipated to generate the highest market value of 95.0 USD Million. Read More

How much is the Transcutaneous segment expected to be valued in 2035?

The Transcutaneous segment of the US Peripheral Nerve Stimulators Market is expected to be valued at 60.0 USD Million in 2035. Read More

Who are the major players in the US Peripheral Nerve Stimulators Market?

Major players in the US Peripheral Nerve Stimulators Market include Bioness, Medtronic, Boston Scientific, and Abbott Laboratories. Read More

What is the expected market value for the Percutaneous product type in 2024?

The Percutaneous product type is expected to be valued at 40.0 USD Million in 2024. Read More

What growth opportunities exist within the US Peripheral Nerve Stimulators Market?

Growth opportunities are present due to increasing demand for effective pain management and advancements in technology. Read More

What challenges might the US Peripheral Nerve Stimulators Market face?

The market may face challenges such as regulatory hurdles and the high cost of devices impacting adoption rates. Read More

Are there any emerging trends in the US Peripheral Nerve Stimulators Market?

Emerging trends include a shift towards minimally invasive procedures and increased focus on personalized medicine. Read More

US Peripheral Nerve Stimulators Market

ID: MRFR/HC/11311-HCR

200 Pages

Rahul Gotadki

Last Updated: April 06, 2026

US Peripheral Nerve Stimulators Market Research Report By Product Type (Transcutaneous, Percutaneous, Implantable), By Device (Stimulators, CPNB Catheters, Pain Pumps, Others), By Stimulating Feature (Stimulator Machines with Train of Four (TOF) Monitoring Features, Machines Without TOF Features) and By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Others) - Growth & Industry Forecast 2025 To 2035

US Peripheral Nerve Stimulators Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Chemicals and Materials, BY Product (USD Million)
  1. 4.1.1 Transcutaneous
  2. 4.1.2 Percutaneous
  3. 4.1.3 Implantable
2. 4.2 Chemicals and Materials, BY Device Type (USD Million)
  1. 4.2.1 Stimulators
  2. 4.2.2 Continuous Peripheral Nerve Blocks (CPNB) Catheters
  3. 4.2.3 Pain Pumps
3. 4.3 Chemicals and Materials, BY Stimulating Feature (USD Million)
  1. 4.3.1 Stimulator Machines with Train of Four (TOF) Monitoring Features
  2. 4.3.2 Machines Without TOF Features
4. 4.4 Chemicals and Materials, BY End User (USD Million)
  1. 4.4.1 Hospitals & Clinics
  2. 4.4.2 Ambulatory Surgical Centers
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medtronic (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Boston Scientific (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Abbott (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Nevro Corporation (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Stryker (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Nuvectra (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Stimwave Technologies (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Halyard Health (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY PRODUCT
3. 6.3 US MARKET ANALYSIS BY DEVICE TYPE
4. 6.4 US MARKET ANALYSIS BY STIMULATING FEATURE
5. 6.5 US MARKET ANALYSIS BY END USER
6. 6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS
9. 6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
10. 6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
11. 6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
12. 6.12 CHEMICALS AND MATERIALS, BY PRODUCT, 2024 (% SHARE)
13. 6.13 CHEMICALS AND MATERIALS, BY PRODUCT, 2024 TO 2035 (USD Million)
14. 6.14 CHEMICALS AND MATERIALS, BY DEVICE TYPE, 2024 (% SHARE)
15. 6.15 CHEMICALS AND MATERIALS, BY DEVICE TYPE, 2024 TO 2035 (USD Million)
16. 6.16 CHEMICALS AND MATERIALS, BY STIMULATING FEATURE, 2024 (% SHARE)
17. 6.17 CHEMICALS AND MATERIALS, BY STIMULATING FEATURE, 2024 TO 2035 (USD Million)
18. 6.18 CHEMICALS AND MATERIALS, BY END USER, 2024 (% SHARE)
19. 6.19 CHEMICALS AND MATERIALS, BY END USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PRODUCT, 2025-2035 (USD Million)
  2. 7.2.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY STIMULATING FEATURE, 2025-2035 (USD Million)
  4. 7.2.4 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Chemicals and Materials Market Segmentation

Chemicals and Materials By Product (USD Million, 2025-2035)

Transcutaneous
Percutaneous
Implantable

Chemicals and Materials By Device Type (USD Million, 2025-2035)

Stimulators
Continuous Peripheral Nerve Blocks (CPNB) Catheters
Pain Pumps

Chemicals and Materials By Stimulating Feature (USD Million, 2025-2035)

Stimulator Machines with Train of Four (TOF) Monitoring Features
Machines Without TOF Features

Chemicals and Materials By End User (USD Million, 2025-2035)

Hospitals & Clinics
Ambulatory Surgical Centers

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”